MV Hondius Hantavirus Outbreak 2026: Deep Dive into the Andes Virus Crisis at Sea
> Research subject: Andes hantavirus outbreak aboard the Dutch polar expedition cruise ship MV Hondius, April–May 2026 > Research date: 2026-05-09 > Key sources: WHO, ECDC, Africa CDC, GenomicEpi.com, UC Riverside, and others
Key points
- In April 2026, the Dutch-flagged polar expedition cruise MV Hondius (Oceanwide Expeditions, ice class PC6, 147 passengers/crew from 23 countries) departed Ushuaia, Argentina on April 1 for Antarctica and South Atlantic islands. An Andes hantavirus outbreak killed at least 3 people, with 8 total cases (5 confirmed, 3 suspected) and 1 critically ill patient.
- Andes virus is the only known hantavirus with documented human-to-human transmission, with case fatality rates of 40–56% (WHO cites up to 50% for American HPS). No vaccine or specific antiviral exists; only supportive ICU care.
- Ports in Cape Verde (May 3) and Spain's Canary Islands (May 7) refused entry; regional Canary president Fernando Clavijo openly opposed the Tenerife stop. South Africa received two critical patients, confirmed diagnoses via NICD, and traced 62 contacts with no further infections as of May 8.
- WHO, ECDC, and Africa CDC coordinated rapidly; ECDC's May 6 threat assessment rated the risk to the European general population as very low, with 9 EU/EEA member states affected. Three people (2 crew + 1 contact) were medevaced from Cape Verde.
- Confirmed or suspected cases surfaced in the Netherlands, UK, Germany, and Switzerland after passengers dispersed, complicating global contact tracing. The ship, with no remaining symptomatic persons aboard, was expected at Granadilla, Tenerife around May 10.
- Hantaviruses are rodent-borne zoonotic viruses (order Bunyavirales). American strains cause Hantavirus Pulmonary Syndrome (HPS) with 20–50% fatality; Eurasian strains cause Hemorrhagic Fever with Renal Syndrome (1–15% fatality).
- Andes virus (South America; reservoir: long-tailed pygmy rice rat, *Oligoryzomys longicaudatus*) uniquely spreads between humans via respiratory droplets, aerosols, and body fluids, with an incubation period of 1–8 weeks. Virus has been detected in blood, urine, respiratory samples, and breast milk.
- UC Riverside's Prof. Scott Pegan: droplet spread is considered distinct from true airborne transmission, but the cruise ship's enclosed spaces, central air circulation, dense cabins, shared facilities, and distance from ICU-level care made it an ideal amplifier.
- No specific antiviral works: methylprednisolone and ribavirin have shown no benefit; ECMO may improve outcomes but is scarce in remote settings.
- Cape Verde: refused docking; a WHO-supported medical team boarded; helicopter evacuation of 3 patients.
- Canary Islands: regional president Fernando Clavijo demanded an emergency meeting with PM Pedro Sánchez to oppose the stop; decision authority rests with the central government.
- South Africa: treated two critical patients, performed lab confirmation, traced 62 contacts (crew and healthcare workers).
- Multilateral: WHO issued IHR notifications; ECDC deployed experts; Africa CDC advised member states to strengthen port health services; the Netherlands led sealed-charter evacuations; UKHSA and Germany coordinated national evacuations (Düsseldorf screening).
- Where was the index case infected? Possibilities include pre-boarding exposure in Ushuaia (an Andes-endemic area), rodent contact on remote islands, or rodents aboard (not reported). The 1–8 week incubation complicates inference.
- Did human-to-human transmission occur aboard, or did all cases share a single rodent exposure? WHO is investigating close-contact transmission evidence.
- Decontamination of cabins, public areas, HVAC systems, and waste—and when the ship can resume operations—remain unresolved.
- Africa CDC statement (May 5): https://africacdc.org/news-item/statement-on-multi-country-hantavirus-cluster-associated-with-cruise-ship-travel/
- WHO hantavirus fact sheet: https://www.who.int/news-room/fact-sheets/detail/hantavirus
- WHO DG media briefing (May 7): https://www.who.int/director-general/speeches/detail/who-director-general-s-statement-for-the-media---7-may-2026
- ECDC threat assessment (May 6): https://www.ecdc.europa.eu/sites/default/files/documents/TAB-hantavirus-06052026.pdf
- ECDC response activation: https://www.ecdc.europa.eu/en/news-events/ecdc-response-activated
- UC Riverside expert Q&A: https://news.ucr.edu/articles/2026/05/07/hantavirus-cruise-ship-raises-transmission-concerns
- GenomicEpi.com outbreak tracker: https://genomicepi.com/outbreaks/hantavirus-hondius/
- Oceanwide Expeditions news: https://oceanwide-expeditions.com/news
- Andes virus monoclonal antibody paper (PMC): https://pmc.ncbi.nlm.nih.gov/articles/PMC11073648/
Timeline of the outbreak
| Date | Event | |------|-------| | Apr 1 | Departs Ushuaia, Argentina (147 people, 23 nationalities) | | Apr 6 | First symptoms: Dutch male passenger, fever/headache/mild diarrhea | | Apr 11 | First death from respiratory distress en route to Tristan da Cunha | | Apr 24 | Body offloaded at Saint Helena; wife (GI symptoms) disembarks | | Apr 26 | Wife dies in a South African hospital; hantavirus diagnosis confirmed by Dutch authorities via WHO | | Apr 27 | 69-year-old British passenger medevaced to Johannesburg ICU; NICD confirms hantavirus | | May 2 | German female passenger dies of pneumonia-like illness; WHO notified of severe respiratory cluster | | May 3 | Cape Verde refuses port entry | | May 4 | WHO: 7 cases (2 lab-confirmed), 3 dead, 1 critical | | May 6 | Andes strain confirmed; ECDC threat assessment; 3 patients evacuated from Cape Verde | | May 7 | WHO update: 8 cases (5 confirmed), 3 dead; Switzerland confirms 1 returned traveler; Canary Islands reject Tenerife stop | | May 8 | No symptomatic persons remain aboard; ETA Granadilla May 10 |
The pathogen: Andes virus
International response and sovereignty tensions
Open questions
Takeaways
1. Post-COVID border reflexes: ports closed faster and more decisively, straining the IHR's non-rejection principles against sovereign self-protection. 2. Remote-route medical fragility: Antarctic routes can be thousands of kilometers from the nearest ICU; medevac depends on weather, politics, and logistics. 3. Globalization of zoonotic disease: a regionally confined South American virus crossed continents via one ship and dispersed cases across at least five countries. 4. Cruise ships remain structurally vulnerable "floating laboratories," as seen with Diamond Princess in 2020 and MV Hondius in 2026.